On the eve of protein destruction: ubiquitin research begins to pay off.
Garber
Ken
K
D000971:Antineoplastic Combined Chemotherapy Protocols; D002986:Clinical Trials as Topic; D004345:Drug Industry; D006801:Humans; D008025:Ligases / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D025801:Ubiquitin / Q000378:metabolism*
D025801:Ubiquitin; D008025:Ligases